NEXVET BIOPHARMA PUB LTD CO's ticker is NVET and the CUSIP is G6503X109. A total of 17 filers reported holding NEXVET BIOPHARMA PUB LTD CO in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $602,000 | +4.2% | 154,840 | 0.0% | 0.13% | -41.1% |
| Q4 2016 | $578,000 | -10.1% | 154,840 | 0.0% | 0.22% | -22.2% |
| Q3 2016 | $643,000 | -10.7% | 154,840 | 0.0% | 0.29% | -54.9% |
| Q2 2016 | $720,000 | +40.9% | 154,840 | 0.0% | 0.64% | +27.6% |
| Q1 2016 | $511,000 | -3.2% | 154,840 | 0.0% | 0.50% | +9.6% |
| Q4 2015 | $528,000 | – | 154,840 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 877,134 | $3,412,000 | 1.46% |
| Broadfin Capital, LLC | 1,127,200 | $4,385,000 | 0.53% |
| Boxer Capital, LLC | 154,840 | $602,000 | 0.13% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,648,696 | $10,303,000 | 0.11% |
| Latimer Light Capital, L.P. | 104,948 | $408,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 795,000 | $3,093,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 44,400 | $173,000 | 0.00% |
| NORGES BANK | 34,313 | $133,000 | 0.00% |
| Advisor Group, Inc. | 90 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,390 | $9,000 | 0.00% |